Month: May 2024

2106 posts
Travel Technology Innovators JR Technologies and Thomalex Merge, Creating End-to-End Travel Retailing Solutions Provider

Travel Technology Innovators JR Technologies and Thomalex Merge, Creating End-to-End Travel Retailing Solutions Provider

DETROIT, May 6, 2024 /PRNewswire/ — Industry leaders JR Technologies and Thomalex today announce…
IRIS Business Services Introduces "IRIS Myeinvois" SaaS Platform for Seamless e-Invoice Compliance in Malaysia

IRIS Business Services Introduces "IRIS Myeinvois" SaaS Platform for Seamless e-Invoice Compliance in Malaysia

NAVI MUMBAI, India, May 6, 2024 /PRNewswire/ — IRIS Business Services (BSE:…
Blue Owl Capital Hires Fidelity International's Johann Santer to Lead APAC Private Wealth

Blue Owl Capital Hires Fidelity International's Johann Santer to Lead APAC Private Wealth

Johann brings over two decades of APAC financial industry experience across the…
JK LAB+ BIOLOGICAL SKIN CARE PRODUCTS – A BREAKTHROUGH IN THE BEAUTY INDUSTRY IN MALAYSIA

JK LAB+ BIOLOGICAL SKIN CARE PRODUCTS – A BREAKTHROUGH IN THE BEAUTY INDUSTRY IN MALAYSIA

KUALA LUMPUR, Malaysia, May 6, 2024 /PRNewswire/ — Hyperpigmentation is a particular…
FWD Max Wealth offers protection and maximises rewards for milestones in life

FWD Max Wealth offers protection and maximises rewards for milestones in life

Celebrate living with additional three percent paid for special life events KUALA…
ORing Strengthens Presence in the US Railway Market with Cutting-Edge Industrial Networking Solutions

ORing Strengthens Presence in the US Railway Market with Cutting-Edge Industrial Networking Solutions

TAIPEI, May 6, 2024 /PRNewswire/ — ORing Industrial Networking, a leading provider…
Lake Resources Signs Letter of Intent with Argentine Energy Infrastructure Company YPF Luz for Kachi Power Supply

Lake Resources Signs Letter of Intent with Argentine Energy Infrastructure Company YPF Luz for Kachi Power Supply

SYDNEY, May 6, 2024 /PRNewswire/ — Lake Resources N.L. (ASX: LKE; OTC:…
Alphamab Oncology to Present Chinese Clinical Data of JSKN003 for the Treatment of HER2-expressing Solid Tumors for the First Time at the 2024 ASCO Annual Meeting

Alphamab Oncology to Present Chinese Clinical Data of JSKN003 for the Treatment of HER2-expressing Solid Tumors for the First Time at the 2024 ASCO Annual Meeting

SUZHOU, China, May 6, 2024 /PRNewswire/ — Alphamab Oncology (stock code: 9966.HK) announced…